# MR-proADM and CT-proET-1 During ICU Treatment

> **NCT03651635** · — · COMPLETED · sponsor: **University of Zurich** · enrollment: 533 (actual)

## Conditions studied

- Acute Phase Biomarkers
- Medical ICU Admitted Patients

## Interventions

- **DIAGNOSTIC_TEST:** Blood sampling for MR-proADM & CT-proET-1

## Key facts

- **NCT ID:** NCT03651635
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-08
- **Primary completion:** 2019-02-28
- **Final completion:** 2019-02-28
- **Target enrollment:** 533 (ACTUAL)
- **Last updated:** 2021-06-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03651635

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03651635, "MR-proADM and CT-proET-1 During ICU Treatment". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03651635. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*